1. Home
  2. TSLX vs ANIP Comparison

TSLX vs ANIP Comparison

Compare TSLX & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sixth Street Specialty Lending Inc.

TSLX

Sixth Street Specialty Lending Inc.

HOLD

Current Price

$21.65

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$79.99

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSLX
ANIP
Founded
2010
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.0B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
TSLX
ANIP
Price
$21.65
$79.99
Analyst Decision
Buy
Strong Buy
Analyst Count
10
6
Target Price
$23.50
$105.83
AVG Volume (30 Days)
475.7K
404.2K
Earning Date
02-12-2026
02-27-2026
Dividend Yield
9.67%
N/A
EPS Growth
N/A
N/A
EPS
2.04
1.67
Revenue
$464,512,000.00
$826,880,000.00
Revenue This Year
N/A
$44.06
Revenue Next Year
N/A
$9.06
P/E Ratio
$10.38
$47.45
Revenue Growth
N/A
48.87
52 Week Low
$18.58
$52.74
52 Week High
$25.17
$99.50

Technical Indicators

Market Signals
Indicator
TSLX
ANIP
Relative Strength Index (RSI) 49.78 48.17
Support Level $21.11 $76.69
Resistance Level $22.16 $80.29
Average True Range (ATR) 0.37 2.45
MACD -0.01 0.06
Stochastic Oscillator 61.91 54.41

Price Performance

Historical Comparison
TSLX
ANIP

About TSLX Sixth Street Specialty Lending Inc.

Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. It partners with companies across a variety of industries and excel at providing creative solutions to companies with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: